Meeting
2016 Genitourinary Cancers Symposium
Prognostic utility of a multi-gene signature (the cell cycle proliferation score) in patients with renal cell carcinoma (RCC) after radical nephrectomy.
Authors
Todd Matthew Morgan
University of Michigan, Ann Arbor, MI
Todd Matthew Morgan , Rohit Mehra , J. Stuart Wolf , Placede Gangnang Fosso , Brian Orr , Shulin Wu , Zaina Sangale , Steven Stone , Chin-Lee Wu , Adam S. Feldman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 555)
DOI
10.1200/jco.2016.34.2_suppl.555
Abstract #
555
Poster Bd #
F16
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world outcomes of patients with operable renal cell carcinoma from the German translational cancer research consortium (DKTK) network.
First Author: Viktor Grünwald
Poster
2014 ASCO Annual Meeting
Characterization of the mTOR autophosphorylation site, S2481, as a novel biomarker in renal cell carcinoma (RCC).
First Author: Lauren Christine Harshman
Poster
2023 ASCO Genitourinary Cancers Symposium
Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database.
First Author: Franklin Liu
Poster
2022 ASCO Annual Meeting
Renal cell carcinoma in renal transplant recipients: Is there a role for screening?
First Author: Binoy Yohannan